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The effects of 6/85-strain M. gallisepticum (6/85MG) inoculation alone or in
conjunction with a F-strain M. gallisepticum (FMG) over- lay and its timing on the
performance, egg, blood, and visceral characteristics of commercial egg laying hens were
investigated. The applied treatments did not affect layer performance, but did affect yolk
moisture and fatty acids, liver moisture, and plasma protein. The plasma protein and
liver moisture changes may be indicative of the effects of the treatments on the hydration
statuses of the birds during lay, whereas alterations in yolk palmitic, oleic, and linolenic
acid levels with treatment may have been manifested by disturbances in the desaturation
and elongation processes of fatty acid synthesis. Pre- lay 6/85MG inoculations may be a
suitable substitute for pre- lay FMG inoculations and FMG overlays during lay on pre- lay
6/85MG inoculations may provide continual protection without eliciting any subsequent
suppressive affects on performance.

DEDICATION

I would like to dedicate this work to my parents, Richard and Eugenia Viscione.
Despite all the frustration, stress, and struggle, their faith in me never faltered. I would
not have been able to continue my academic career without their help and constant
support. We have been, and always will be, a team. This accomplishment is as much
theirs as mine.

ii

ACKNOWLEDGEMENTS

First and foremost, Dr. Peebles went above and beyond his role as major
professor, and helped me accomplish much more than I’d ever thought possible. His
faith in me and constant reassurance and support was absolutely vital. He has my deepest
gratitude. Ms. Sharon Whitmarsh also went above and beyond as a first rate technician,
therapist, computer whiz, and lab mom. I could not have imagined a more supportive lab
to work in, or a more supportive department to work with. Dr. Morgan’s faith in my
typing abilities set the ball rolling, so these acknowledgements would not be complete
without acknowledging him. My committee, Dr. Kidd, Dr. Branton, Dr. Cummings, and
Dr. Pharr were patient and supportive through countless emails and numerous rambling
voice messages. Their willingness to take this on, and have a sense of humor while doing
so, is appreciated more than I could possibly express. I would also like to acknowledge
Dr. Thaxton as one of the best teachers I’ve ever had the privilege of studying under. He
pushed me to be more and always had absolute faith that I had more of myself to give.
His continued encouragement has meant more than he will ever know. I’d like to
acknowledge the professors, technicians, and secretaries, in the Poultry Science
Department as well as the USDA scientists, technicians, and farm crew. Their generosity
iii

is a continued surprise, and their willingness to laugh as they work makes the job so
much more fun. I was exceedingly lucky to have a great support system of family and
friends. My parents, Richard and Eugenia Viscione, sister and brother- in- law, Michael
and Erin Fowler, and grandmothers, Loretta Gabriel and Lillian Viscione were fabulous
sounding boards.

iv

TABLE OF CONTENTS
Page
DEDICATION.....................................................................................................................ii
ACKNOWLEDGEMENTS ................................................................................................iii
LIST OF TABLES ..............................................................................................................vi
CHAPTER
I.

INTRODUCTION .............................................................................................1

II.

REVIEW OF LITERATURE ............................................................................3
The Avian Reproduction System.......................................................................3
Hormonal Influences on Avian Reproduction...................................................5
Composition of the Avian Egg ..........................................................................7
Avian Lipid Metabolism....................................................................................8
Mycoplasma gallisepticum...............................................................................10
Hosts of M. gallisepticum ................................................................................10
Isolation and Detection of M. gallisepticum ....................................................11
The Virulence and Transmission of M. gallisepticum .....................................13
Economic Impacts of M. gallisepticum ...........................................................14
Pathological Symptoms of M. gallisepticum Infection....................................15
Treatment of M. gallisepticum Infected Birds .................................................15
Prevention of M. gallisepticum Infection.........................................................17
Effects of M. gallisepticum Infection on Layer Performance ..........................18
Effects of F and 6/85-strain M. gallisepticum on the Blood
Characteristics of Laying Hens .......................................................................19
Effects of M. gallisepticum Infection on Layer Necropsy Results ..................21

v

III.

MATERIALS AND METHODS .....................................................................22

Pullet Housing and Management .....................................................................22
Layer Housing and Management .....................................................................23
Pullet and Layer Diets......................................................................................23
6/85 MG and FMG Inoculation .......................................................................24
Mycoplasma Detection ....................................................................................24
Data Collection ................................................................................................25
Quantitation of Yo lk Moisture and Lipid Content...........................................27
Liver Moisture and Lipid Content ...................................................................28
Blood and Serum Constituents.........................................................................28
Statistical Analysis ...........................................................................................29
IV.

RESULTS ........................................................................................................31

V.

DISCUSSION ..................................................................................................35

VI.

SUMMARY.....................................................................................................42

REFERENCES ..................................................................................................................53

vi

LIST OF TABLES

TABLE

Page

1.

Titers used in 6/85MG @ 10 wk, FMG @ 22 wk, and FMG @ 43 wk
of age inocula in Trials 1 and 2..................................................................44

2.

Body weight in age intervals I (20 wk), II (24, 32, and 43 wk),
and III (47 wk) ...........................................................................................45

3.

Weekly egg production (EP; % hen day) in hen age intervals II (23-44 wk)
and III (45-54 wk)......................................................................................46

4.

Weekly egg weight (EW) in hen age intervals II (23-44 wk)
and III (45-55 wk)......................................................................................47

5.

Percentage yolk weight (% of egg weight) in age interval
II (24, 32, and 43 wk).................................................................................48

6.

Egg yolk moisture concentration in control, 6/85MG at 10 wk
(6/85MG-10), and 6/85MG at 10 wk and FMG at 22 wk
(6/85MG-10, FMG-22) treatment groups in age interval II
(across 24, 32, and 43 wk) .........................................................................49

7.

Yolk Palmitic, oleic, and linolenic acid concentrations, (% of total
yolk fatty acids) in control, 6/85MG at 10 wk (6/85MG-10),
6/85MG at 10 wk and FMG at 22 wk(6/85MG-10, FMG-22),
and 6/85MG at 10 wk and FMG at 45 wk (6/85MG-10,
FMG-45) treatment groups at age interval II (58 wk of age) ....................50

8.

Hen liver moisture concentration in control, 6/85MG at 10 wk
(6/85MG-10), 6/85MG at 10 wk and FMG at 22 wk (6/85MG-10,
FMG-22), and 6/85MG at 10 wk and FMG at 45 wk (6/85MG-10,
FMG-45) treatment groups in age Interval III (58 wk of age)...................51
vii

9.

Plasma total protein concentration in control, 6/85MG at 10 wk
(6/85MG-10), and 6/85MG at 10 wk and FMG at 22 wk
(6/85MG-10, FMG-22) treatment groups in age interval II
(24, 32, and 43 wk) ....................................................................................52

vii

CHAPTER I
INTRODUCTION

Mycoplasma gallisepticum (MG) is a small eubacterium that lacks a cell wall and
is weakly gram- negative. Mycoplasma infections have been shown to reduce the
performance of commercial laying hens, leading to significant economic losses (Yoder
and Hofstad, 1964; Domermuth et al., 1967; Mohammed et al., 1987; Patterson, 1994).
Mycoplasma is found in many types of birds, including chickens and turkeys. The
known strains of MG include the following: S6 (S6MG), R, F (FMG), 6/85 (6/85MG),
PG31, ts-11, 1150, MR3, A 5669, Connecticut F strain, and ATCC 15302 (McMartin,
1967; Carpenter et al., 1979; Hildebrand et al., 1983; Levinsohn et al., 1985; Yagihashi,
1988; Evans and Hafez, 1992; Sudhir et al., 1998; Branton et al., 2000; Marois et al.,
2001). While vaccines are commercially available to help lower the loss of production in
commercial layers, the vaccines themselves can cause drops in production. The FMG
strain is known to depress the egg production (EP) of layers when inocula are
administered at 10 or 22 weeks. When administered prelay or at lay initiation, the
6/85MG is known to disrupt layer EP less than FMG, but it does not protect as well as
FMG from the more virulent strains of MG (Eleazer, 2000). There are possible benefits
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of using a prelay 6/85MG inoculation in conjunction with FMG inoculations during lay
to effectively protect flocks against field strain MG infections, while reducing possible
subseque nt depressions in EP due to a prelay FMG inoculation. Commercial operations
may acquire flocks already inoculated with 6/85MG, but desire to continue using the
FMG inoculation regime familiar to them. Therefore, the goal of this study was to
investigate the effects of a 6/85MG inoculation prelay overlaid with FMG inoculation
during lay on the performance, blood, internal egg and eggshell, and reproductive and
digestive organ characteristics of commercial layers.
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CHAPTER II
REVIEW OF LITERATURE

The Avian Reproductive System
Ovaries in birds are both present at all embryonic stages, but primordial germ
cells to the ovaries of the bird begin to become asymmetrically distributed by the fourth
day of incubation, and regression of the right oviduct begins by Day 10. Therefore, only
the left ovary and oviduct are functional in the adult female except for a rare case of right
oviduct development (Romanoff & Romanoff, 1949; Kinskey, 1971). The mesovarian
ligament attaches the left ovary to the left kidney on the cephalic end. The number of
oocytes in the chick embryo rises, falls, and usually ends with 480,000 when oogenesis is
terminated. Oogenesis is terminated at hatch (roughly 21 days). Only 200-500 of these
oocytes reach maturity and are ovulated in the life span of the bird. There is a follicular
hierarchy in the functionally mature ovary with 4-6 large yolk filled follicles, a greater
number of smaller yellow follicles, and numerous small white follicles.
The mature follicle consists of layers of tissue with concentric properties. These
tissues surround the oocytes and yolk. The tissues include: (1) the oocytes plasma
membrane, (2) the perivitelline membrane, (3) granulosa cells, (4) basal lamina, and (5)
the theca (interna and externa). Follicles are ovulated in order of the follicular hierarchy
3

and any enlarged, yolk filled follicles that fail to be ovulated become atretic. The avian
oviduct has five distinct regions: infundibulum, magnum, isthmus, shell gland, and
vagina.
The infundibulum is a funnel-shaped section of oviduct that is not directly
attached to the ovary itself. The ovum is “caught” by the infundibulum and remains there
for approximately 18 minutes (Warren and Scott, 1935). This is also the site for the
deposition of the first layer of albumen (Gilbert, 1979). The magnum is the largest
portion of the oviduct (33 cm in the chicken) and is the site for the majority of albumen
formation. The magnum is highly glandular, containing tubular glands responsible for
the production of ovotransferrin and ovomucoid (Aiken, 1971 and Tuohimaa, 1975). The
magnum contains the ovum for 2-3 hours and is the beginning of calcium secretion
(Eastin and Spaziani, 1978a). The isthmus is the next section of oviduct and has less
glandular tissue than the magnum, but more muscle mass. The isthmus has tubular gland
cells overlaid with epithelial cells. The ovum remains in the isthmus one to two hours,
and forms both inner and outer shell membranes.
The uterus, or “shell gland”, is characterized by a prominent muscle layer lined
with both tubular and unicellular goblet cells (Johnson, 1986). The egg absorbs salts and
about 15g of water before calcification, this process is termed “plumping” (Wyburn et al.,
1973). The egg remains in the uterus for 20-26 hours. Calcification takes about 15
hours, and pigmentation takes roughly 5 hours (Warren and Conrad, 1942). The vagina
is defined from the uterus by the utervaginal sphincter muscle and ends at the cloaca.
While the uterus contains many fold s of mucosa lined by both ciliated and nonciliated
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cells, secretory glands are absent. While the vagina and uterus work in tandem to expel
the egg, the vagina plays no role in the formation of the egg.
Contractions of the oviduct transport the egg to the oviduct which functions as a
stretch receptor. The ovum produces the mechanical stimulus (Arjamaa and Talo, 1983).
Johnson (1986) suggests that ovum transport through the oviduct and expulsion of the
egg from the shell gland may involve prostaglandin-stimulated contractility of oviduct
smooth muscle.
To allow the egg to pass through the cloaca, the abdominal muscles and sphincter
between the shell gland and vagina, as well as muscular contractions of the uterus must
occur (Johnson, 1986).

Hormonal Influences on Avian Reproduction
The highest concentrations of the hormones progesterone and estrogen occur in
the preovulatory follicles, while concentrations of testosterone decrease in the largest
preovulatory follicle 6-8 hours prior to ovulation (Shahabi et al., 1975). Estrogen is
produced by thecal tissue (Johnson, 1986). Lutenizing hormone plasma concentrations
peak 4-6 hours prior to ovulation (Lague et al., 1975; Johnson and van Tienhoven, 1980a;
Etches and Cheng, 1981). This is considered a necessary part of ovulation. This peak
also coincides with the peak of progesterone (Etches and Cheng, 1981). Etches and
Cheng (1981) assert that there is an additional peak of LH at 14-16 hours prior to
ovulation. Testosterone shows a peak preovulatory concentration occurring 10-6 hours
prior to ovulation. Testosterone is secreted from at least the four largest follicles. The
highest levels of 5a-dihydrotestosterone (DHT) peak at 6 hours before ovulation (Etches
5

et al, 1981). Ovulation can occur without testosterone or DHT, indicating they are not
directly involved in ovulation (Johnson, 1986). Corticosterone displays both a daily
rhythm and a peak coincident with oviposition, but no increase related to ovulation
(Johnson and van Tienhoven, 1981d). A peak in follicle-stimulating hormone (FSH) 15
hours prior to ovulation has been observed and occurs coincidentally with an increase in
FSH binding in the ovarian tissues (Scanes et al., 1977a; Etches and Cheng, 1981).
Calcium in the blood is circulated in two different forms. One form is
nondiffusible protein-bound calcium (unionized) and the other is diffusible ionized
calcium. Plasma calcium-binding proteins, vitellogenin, and albumen bind nondiffusible
calcium (Guyer et al., 1980). Estrogen increases the amount of these binding proteins,
thereby increasing blood calcium levels (Bacon, et al., 1980). Layers not fed an adequate
amount of calcium in their diets can experience a significant decrease or complete halt of
egg production (EP) and regression of the ovary within 6-9 days (Taylor et al., 1962;
Luck and Scanes, 1979a). Voluntary calcium consumption of layers increases when the
egg enters the uterus as well as the period of eggshell calcification (Mongin and Sauveur,
1974).
Photoperiods are essential for EP in layers. Ovarian development is impacted
most by 12-14 hours of light, although optimal production has been achieved by up to 18
hours of light. Hens can continue to lay in complete darkness, but production will be
decreased (Wilson and Woodward, 1958; Morris, 1968).
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Composition of the Avian Egg
The egg is composed of albumen, yolk, an organic matrix, and the shell. The
albumen is comprised of four distinct layers: (1) a chalaziferous layer which is attached
to the yolk (~2.7%); (2) an inner liquid layer (~16.8%); (3) a dense, thick layer (~25%);
and (4) an outer thin, fluid layer (~50%). The organic matrix has four distinct layers as
well. These consist of the shell membranes, the mammillary cores, the shell matrix, and
the cuticle. The isthmus is principally responsible for producing the shell membranes,
although there are still questions about whether the epithelial or tubular gland cells are
responsible. These membranes contain protein fibers cross- linked by disulfide and
lysine-derived bonds with small fibrous protuberances of unknown function creating a
meshwork. Passage of water and crystalloids are permitted by the semipermeable
membranes, and while there is no relationship between the membrane thickness and shell
thickness, both decrease with age. The outer shell membrane is embedded within the
mammillary core (Johnson, 1986). This has been proposed as the initial site of
calcification (Stemberger et al, 1977) and represent s the greatest proportion of the
organic material of the eggshell. The mammillary cores are comprised of
mucopolysaccharides and sulfated proteins which are thought to be formed by the
isthmus epithelial cells. The shell matrix is composed of a series of layers of protein as
well as acid mucopolysaccharides where calcification takes place. The shell matrix
completes approximately 2% of the organic composition of the eggshell and along with
calcified crystals makes up the palisade layer of the shell. This la yer is deposited soon
after the egg reaches the uterus. A thin waxy cuticle covers the surface of the egg. The
cuticle is comprised of proteins, polysaccharides, and lipids (Johnson, 1986). The cuticle
7

ranges in depth of 0.5 to 12.8 µm due to an uneven distribution (Parsons, 1982). The
source of the cuticle is not known, and it adds little to the structural integrity of the egg.
The function of the cuticle is believed to protect the egg from evaporation and microbial
invasion.
The eggs calcified portions can be divided into the mammillary knob layer, the
palisade layer, and the outer surface crystal layer. The mammillary knob is formed from
outward crystallization of the mammillary cores. The mammillary knob is formed in the
uterus in the first 5 hours of calcification. Plumping stretches the membranes by water
passage and increases distance between the tips of the mammillace. Crystals form
laterally and grow to eventually coincide with crystals from other mammillae. Crystals
that grow outward may extend to the shell surface (Johnson, 1986). The crystallized
palisade is also termed the spongy layer, and is composed mainly of calcite and
constitutes the greatest portion of the shell (~200 µm thick). Approximately 5-6 hours
after the egg has entered the uterus, the calcification of this layer is initiated during a
process termed “plumping”.

Avian Lipid Metabolism
Fatty acids can be characterized as saturated or unsaturated as well as essential or
nonessential. Avian requireme nts for lipids are for relatively small amounts of the few
fatty acids that cannot be synthesized by the bird’s body (arachidonic, linolenic, and
linoleic). These fatty acids that cannot be synthesized make up the essential fatty acids.
However, arachidonic acid can be procured from linoleic acid, and, therefore, a dietary
supply of linoleic acid can satisfy the need for arachidonic acid. The liver and
8

extrahepatic tissue is the main source of fatty acid synthesis. There are two major
enzyme systems involved in the synthesis of fatty acids in birds. Acetyl-CoA
carboxylase (a biotin dependent enzyme) is the first, and the multienzyme system fatty
acid synthetase is the second (Parkhurst and Mounthey, 1987; Kleven, 2003).
Lipase activity in the small intestine as well as in the stomach hydrolyze
triglycerides to diglycerides, monoglycerides, fatty acids, and glycerol (Johnson, 1986).
During this digestion, micelles are formed and eventually absorbed into the small
intestine. Cholecystokinin induces panc reatic enzyme secretion in response to lipid
entrance into the digestive tract (Dockray, 1975). Villi of the small intestine absorb fatty
acids and the lipids are transported by the portal blood system as portomicrons after being
esterified (Bensadoun and Rothfeld, 1972; Frazer et al., 1986).
Metabolism of lipids is regulated by various hormones. Glucose is the end
product of carbohydrate digestion and becomes a major precursor of lipids. Glucagon
and insulin are essential factors in the regulation of lipogenesis. Glucagon affects
lipolytic and antilipogenic hormone while insulin stimulates lipogenesis. Avian
pancreatic peptide reduces the concentration of circulating free fatty acids and partially
suppresses lipolysis by glucagon. Insulin inhibits the release of glycerol and free fatty
acids in adipose tissue and also stimulates the conversion of glucose to fat. By
stimulating the lipoprotein lipase, incorporation of circulating triglycerides into cells
increases.
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Mycoplasma gallisepticum
Mycoplasmas are very small (0.25-0.50 µm) prokaryotes. They lack a cell wall
and are bound by a plasma membrane which makes them resistant to antibiotics that
affect cell wall synthesis or complex nutritional requirements (Kleven, 2003).
Mycoplasma has a thin trilaminar cell memb rane and consist of only three organelles; a
cell membrane, ribosomes, and circular double-stranded DNA molecule. Mycoplasmas
exploit their limited genetic material and are successful as pathogens. Mycoplasmas
infect by entering the host, multiplying, evading defense mechanisms, causing damage,
and escaping to infect new hosts. It targets tissues with epithelial surfaces, such as the
respiratory tract, and cause lesions by stimulating the host’s inflammatory and cellular
responses. Mycoplasma is able to evade the host’s immune system by varying their
major surface antigens (Bradbury, 2005). Mycoplasmas colonize mucosal surfaces.
Mycoplasmas are of the class Mollicutes, Family I Mycoplasmataceae, and Genus I
Mycoplasma. Usually noninvasive, M. gallisepticum is now known to penetrate cells
(Kleven, 2003). M. gallisepticum (MG) is weakly gram negative and penicillin resistant
(Kleven, 2003)

Hosts of M. gallisepticum
Mycoplasma tends to be host specific and affect a broad range of animals, plants,
and insects. Mycoplasma organisms have been isolated from varying species of birds
such as pheasants, chukar, partridges, peafowl, as well as chickens, turkeys, duck, geese,
and other processed birds. M. gallinaeceum, M. gallinarium, M. gallisepticum, M.
glycophilum, M. iners, M. lipofacies, M. pullorum, and M. synoviae (MS) affect
10

commercial flocks of chicken. Turkeys alone are affected by M. melegridis and M.
iowae, while MS and MG are pathogenic for both chickens and turkeys (Kleven et al.,
1998). M. imitans was isolated from ducks, geese, partridges, and others and was found
to be closely related to MG. While studying the pathogenicity of M. imitans in chicks no
clinical signs or lesions were found with a single infection, however, sinusitis, tracheitis
and airsacculitis were found in birds where infection was associated with MG and
infectious bronchitis virus. Therefore, it is believed that M. imitans act synergistically
with other pathogenic agents.

Isolation and Detection of M. gallisepticum
Every species of Mycoplasma requires the presence of cholesterol to grow in
media. The growth media must be protein rich and contain 10-15% swine or horse heatinactivated serum. A further supplication of a yeast-derived component is found to be
beneficial as well. Frey’s medium is a commonly used growth media for MG. M.
gallisepticum is a slow growing organism, and is resistant to thallium acetate and
penicillin, which are frequently used in the media to retard the growth of contaminant
bacteria and fungi. Plates that are inoculated must be incubated in a very moist
atmosphere for 3-10 d at 37-38°C. Colonies of MG are small (0.1-1.0 mm), smooth,
circular, and flat with a denser, raised central elevation. Differences between colony
morphology have been noted, but cannot be relied upon to differentiate between the
various species. Individual colony cells can vary from 0.2-0.5 µm and are generally
coccoid to coccobacilliform; however slender rods, filaments, and ring forms have been
described. Mycoplasma species usually ferment glucose, hydrolyze arginine, and exhibit
11

phosphatase activity. This fermentation is a common trait among MG, MS, M.
gallinaeceum, M. glycophilum, M. pullorum, and M. gallinarium. M. iners hydrolyses
arginine while M. lipofacies ferments glucose and hydrolyses argentine (Kleven, 2003;
Kleven, 1997).
Mycoplasma organisms are able to remain viable for 3 days in an outer
environment, 18 weeks in egg yolk kept at 37°C, and 1-3 days in chicken feces at 20°C
(Chandiramani et al., 1996). M. gallisepticum organisms may remain viable for 32-60
days if stored in a refrigerator, but do not remain stable at elevated temperatures. Broth
MG cultures remain viable for several years if stored at -30°C (Yoder and Hofstad,
1964). After an outbreak of a MG infection, the level of infection in a flock or at a farm
may decrease. This decrease results from the birds shedding the organisms into the
environment, explaining the dangers in multiage farms where incoming birds are
introduced to the constant source of MG in the farm environment (Butcher et al., 1998).
While swabbing for MG, it has been reported that the type of swab used may influence
the growth rate of MG organisms in infected birds (Shah-Majid, 1986; Shah-Majid and
Nihayah, 1987). It has also been noted that the type of swab used may influence the
growth rate of MG organisms in media. The effectiveness of plain/charcoal swabs on
wooden or plastic sticks to rayon swabs on aluminum wire was compared. Three types of
Mycoplasma were used in the comparison: S6 strain, B6/93 strain, and J35/86 strain.
Plain/charcoal swabs on wooden or plastic sticks were used when better differentiated
positive and negative results were found. Rayon swabs on aluminum wire inhibited
Mycoplasma organism’s growth during the incubation period (Zain et al., 1995).
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False diagnosis results (positive or negative) can cause great economic losses, so
there are several methods that may be used to detect infection. These include
hemagglutination inhibition (HI), serum plate agglutination (SPA), enzyme linked
immunosorbent assay (ELISA), and fluorescent antibody (FA) tests. Nonspecific
reactions with MS have been reported with SPA, HI, and ELISA tests (Yoder and
Hopkins, 1985; Kleven et al., 1988; Yoder, 1989; Dingfelder et al., 1991; Kempf et al.,
1997).
HI titers are strongly positive at 1:80, strongly suspected at 1:40, and negative for
MG negative at 1:20. The effectiveness of HI and ELISA tests in the detection of a
laboratory and field strain of MG was tested by Czifra et al. (1995). A5969 strain was
used as a hemagglutinating antigen. Of inoculated birds, 62.7% were detected to be MG
positive by the HI test, whereas the same birds were found to be 83% positive by ELISA.
False negative results with birds infected with the K703-strain of MG were reported in
commercial ELISA kits. False negative results in ELISA could be explained by the
inability of some strains of Mycoplasma to inhibit the activity of the A5969 strain used in
the ELISA (Kempf et al., 1997). A more reliable technique than ELISA is the FA
technique (May et al., 1997). Mycoplasma species can be differentiated by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SAS-PAGE), Southern blot, or by
restriction endonuclease analysis (RFLP) (Kleven et al., 1988).

The Virulence and Transmission of M. gallisepticum
Strains of MG vary in virulence, tissue tropism, antigenic makeup, and are
capable of altering the expression of major surface proteins (Garcia, et al., 1994). The
13

following strains of MG are those known to date: F (FMG), 6/85 (6/85MG), K503, K530,
R, S6, PG-31, TS-11, 1150, K1453, K1501, MR3, M1148, A5969, Connecticut F strain,
and ATCC 15302 (McMartin, 1967; Carpenter et al., 1979; Hildebrand et al., 1983;
Levinsohn et al., 1985;Yagihashi, 1988; Evans and Hafez, 1992; Sudhir et al., 1998;
Branton et al., 2000; Marois et al., 2001). RMG strain MG appears to be more virulent
than FMG, which is considered to be moderately virulent. The 6/85 strain MG is
considered low virulence (Kleven, 2003).
It is thought that phenotypic switching could provide a specific adaptation
mechanism to the surrounding environment. Phenotypic switching is believed to be the
differential expression of pMGA genes. This effect was discovered in vitro, and it is
suggested that such an event enables the MG to better adhere to its host (Athamna et al.,
1997).
It has been shown that MG organisms are able to adhere to the epithelial surface
of the respiratory tract of chickens by terminal bleb structures (Maniloff and Quinlan,
1973). It’s been suggested that while the primary location of MG infection colonization
is the respiratory system, the invasion of other organs is possible. Migration of MG
through the blood stream from the mucosal membrane of the respiratory system to other
organs may occur via attachment to erythrocytes (Winner et al., 2000).

Economic Impacts of M. gallisepticum
In 1994, economic losses due to MG infection of commercial laying flocks in the
US were up to $118 and $150 million annually. California lost approximately $127
million due to a MG outbreak in 1984 and $6.5 million due to decreased EP and disease
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prevention programs (Patterson, 1994). At least 75% of multi-age layer farms in the
industry are positive for MG. This is the most pathogenic and economically significant
pathogen in poultry. Air sac infections cause significant economic decreases by causing
condemned carcasses in processing plants. This, along with reduced feed and EP
efficiency, as well as increased medication costs, combine to make this one of the
costliest diseases confronting commercial poultry production. In addition to the costs of
the disease, costs are further increased by prevention and control methods, such as
vaccinations (Kleven, 2003). Despite short survival times in the environment, MG is able
to successfully transmit to new hosts horizontally and vertically (hen to egg) in flocks.
The horizontal transmission is accentuated by intensive husbandry practices as well as
stress factors. Although costly, vaccination programs help prevent the high morbidity
and mortality is usually attributed to a second infection (Newcastle, bronchitis, E. Coli,
etc).

Pathological Symptoms of M. gallisepticum Infections
M. gallisepticum infections are characterized by respiratory symptoms such as
respiratory rales, coughing, nasal discharge, and conjunctivitis (Klevens, 2003). These
signs vary from bird to bird, and between species. The severity of symptoms depends on
the strain of MG (Klevens, 2003), environmental conditions, ammonia concentration in
the air, stress, and the presence of other pathogenic factors (Sato et al., 1973; Zander,
1984; Mohammed et al., 1987b). For example, MG infection of embryos can
subsequently result in inflammatory processes and changes in the joints of young chicks
(Chute and Cole, 1954). While symptoms may be slow to develop, the infection may
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have a long course. M. gallisepticum is able to pass through mucosal barriers to cause
systemic infections, and has been isolated from the respiratory system, brain, periovarian
region, oviduct (including uterus and vagina), liver, spleen, and cloaca (Kleven, 2003).

Treatment of M. gallisepticum Infected Birds
Mycoplasma is susceptible to a number of antibiotics: tylosin, tiamulin,
gentamicin, tetracycline, streptomycin, erythromycin, spiromycin, valnemulin,
enrofloxacin, lincomycin, and spectinomycin (Ose et al., 1979; Jordan et al., 1998;
Timms et al., 1989). Enrofloxacin administered to infected layers through drinking water
normalized EP in 3 weeks, and also reduced level of egg transmissions of MG. Only
0.05% of live embryos were shown to be MG positive in antibiotic-treated groups when
cultured, whereas 12.8% of all fertile eggs in control birds were MG positive. However,
lincomycin and spectinomycin were less successful in preventing MG transmission
through the egg (Ortiz, 1995; Jordan et al., 1998). Tilmicosin was shown to reduce the
incidence and severity of airsacculitis caused by MG infection in birds when
administered for 3-5 days via drinking water (Charleston, 1998). M. gallisepticum is able
to induce a cross-resistance to antibiotics over several in vitro passages. High cross
resistance was demonstrated for streptomycin, erythromycin, spiromycin, tylosin, and
enrofloxacin. Little induced resistance was demonstrated for streptomycin,
chlortetracycline, or enrofloxacin.
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Prevention of M. gallisepticum Infections
Mycoplasma organisms are very susceptible to disinfection, so biosecurity is a
crucial factor in preventing MG infections. However, this problem is complex as many
farms contain flocks composed of many different ages. This cycling of birds makes
eliminating an infection extremely difficult, if not impossible.
Protection against the highly pathogenic field strains of MG involves vaccination
with live-attenuated and killed (bacterins) vaccines. Vaccination programs also defend
flocks from drastic production drops. The bacterins of MG with oil-emulsion adjuvant
protected young flocks from intrasinus challenge with virulent MG and commercial
layers from the drastic EP drops mentioned above. While bacterins have proven effective
in reducing colonization by MG, it usually does not eliminate the organisms completely.
Because of this, and the cost of two vaccinations and handling individual birds, bacterins
are not considered useful in long term control of MG.
Live FMG strain vaccines have been used in live culture pullet vaccination
programs and extensively in multiple-age laying complexes to prevent or reduce MGcaused EP losses (Carpenter, 1981; Glisson, 1984; Rodriguez, 1980; Kleven, 2003) and
provided protection against airsacculitis following aerosol challenge with RMG. The
biologic mechanism underlying the protection offered by FMG vaccinations was found
not to involve competition for adherence sites or blockage by prior colonization,
furthermore, the FMG vaccination did not prevent colonization by the challenge strain of
MG (Levisohn et al., 1987). FMG can be transmitted through the egg (Lin et al., 1982)
as well as among penmates (Evans et al., 92; Kleven, 1981). This transmission is altered
by administration techniques. Administering the vaccine through a right-eye drop
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prevents transmission from bird to bird if an empty pen or aisle is between the birds
(Kleven, 1981). This type of administration also produced birds with higher EP as
compared to unvaccinated MG infected flocks, but not as high as control birds (MG-clean
flocks) (Carpenter et al., 1981; Mohammed et al., 1987). Flocks vaccinated with FMG
maintain the organism in the upper respiratory tract for life (Kleven, 1981). In studies
FMG vaccines reduced the population of a challenge or field strain in the upper
respiratory tract and in pen trials F strain vaccination effectively displaced challenging
infections (Cummings et al., 1986; Levisohn et al., 1987; Kleven et al., 1998). F-strain
MG vaccination programs managed to successfully displace field-strain MG from
multiple-age layer complex using 2 years of continuous vaccination for replacement
pullets (Kleven et al., 1990). F-strain MG vaccine can be administered by several
methods including eye-drop, intranasal, and coarse spray (Levisohn et al., 2000).
Administration of the vaccine can begin as early as 2 weeks or less if risk of exposure is
great, but is usually administered at 8-14 weeks of age (Levisohn et al., 2000).
The 6/85-strain of MG originated in the United States, and its development and
vaccination characteristics are described by Evans et al, 1992. (Evans et al., 1992). When
6/85MG vaccines were studied, minimal virulence, rare to no transmissibility, and
resistance to challenge with virulent MG were noted (Abd, 1993; Evans, 1992; Evans et
al., 1992). The 6/85MG vaccine is administered by spray and while it results in little or
no detectable serologic response, it can be detected in the upper respiratory tract for 4-8
weeks after administration of vaccine (Abd, 1993; Evans, 1992; Ley, 1997). 6/85-strain
MG vaccines have been used in the United States for prevention of EP losses in the
commercial table egg layers. The vaccine (Noblis MG 6/85, Intervet Inc., Millsboro,
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Delaware, USA) is presented to the birds in a freeze-dried pellet and administered as a
single dose to pullets 6 weeks of age or older; however, to be fully effective, the vaccine
must be administered by the aerosol route (Kleven, 2003). Due to its safety comparable
to the FMG, 6/85MG vaccination is a desirable alternative when vaccinating susceptible
flocks (Levisohn et al., 2000). While 6/85MG affects EP less than FMG, it is not able to
displace field strain infections equally (Levisohn et al., 2000).

Effects of M. gallisepticum Infection on Layer Performance
M. gallisepticum causes a decrease in EP along with respiratory disease
(Patterson, 1994) and feed consumption in laying hens (Yoder and Hofstad, 1964;
Domermuth et al., 1967; Mohammed et al., 1987a; Patterson, 1994). Patterson (1994)
also reported that the reduced EP and egg quality in laying hens is a result of the spread
of infection from the respiratory system to the oviduct. In a separate report hens
inoculated with FMG at 12 weeks of age experienced a delay in EP compared to control
birds. This delay was approximately 1 week. There was also a significant decrease in EP
after week 42, and FMG-treated birds produced 19 fewer total eggs than control birds
(Burnham et al., 2002a). M. gallisepticum has also been shown to reduce the overall
growth rate of chickens (Butcher, 1998) as well as affecting the eggshell forming
mechanisms (Domermuth et al., 1967). Burnham et al (2003c) also asserted that FMG
infection affects yolk lipid (significantly higher at weeks 32 and 44, and lower at week
48) and cholesterol concentrations (decreased at week 22) as well as fatty acid
composition. Yolk linoleic, stearic and arachidonic acids were increased, while
concentrations of palmitoleic and oleic acids were decreased. These yolk lipid
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concentration differences may be due to adaptations to infection, where the yolk fatty
acid concentrations are indicative of changes in liver lipid synthesis. While the effects of
FMG on performance are noted by Burnham (Burnham et al., 2002a) among others,
6/85MG is lacking in literature documenting its effect on performance.

Effects of F and 6/85-strain M. gallisepticum on the Blood Characteristics of Laying
Hens
There is little literature that reports the effects of MG on the blood characteristics
(such as HCT, STRIG, SCHOL, SCA, and PP). Nevertheless Burnham et al. (2003a)
reported levels of HCT, STRIG and PP were affected by FMG inoculations. The HCT
levels of birds inoculated with FMG at 12 weeks of age was lower 8 weeks post
inoculation when compared to Control birds. M. gallisepticum-inoculated hens had
increased levels of STRIG and PP during pre-peak EP, but decreased levels in post-peak
EP. It has been suggested that increased HCT, STRIG, and PP leve ls were due to an
adaptive immunological response toward the infection. It has been reported that the
higher levels of STRIG are associated with an immunological response to infection
(Guyton and Hall, 1996). The increased levels of STRIG and PP between 20 and 22
weeks suggest the birds are stressed, further decreasing their immunity toward the FMG.
Lower levels of STRIG and PP post-peak EP may accelerate follicular regression,
increasing the incidence of fatty livers, and inhibiting liver lipid and protein synthesis.
Decreased blood lipid levels may also lead to changes in the deposition of yolk lipid and
cholesterol (Burnham et al., 2003a).
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Effects of M. gallisepticum Infection on Layer Necropsy Results
Significant effects due to FMG were reported by Burnham et al. (2002b) on
magnum length, isthmal and vaginal weights, and the number of mature ovarian follicles.
The reduced magnum length of FMG-infected hens is thought to alter albumen deposits.
The decreases in isthmal and vaginal weights are thought to impact EP.
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CHAPTER III
MATERIALS AND METHODS

Pullet Housing and Management
In both trials, 1-d-old Hy- Line w-36 Leghorn pullets were obtained from a
commercial hatchery certified free for MG and MS (USDA-APHIS-VS, 2003). Until 10
weeks of age, birds were raised on clean dry litter, in a 5.5 x 6.1 m section of a
conventional house, on a USDA facility. Initial flock density was 0.034 m2 / bird. In the
conventional house, a daily artificial lighting schedule followed a 13 L : 11 D cycle. One
75-Watt light bulb was used to illuminate each 8.4 cm2 of floor space, providing a 35.5 lx
intensity at bird level.
At 10 day of age, all pullets were vaccinated for infectious bursal disease. At 12
days and at 4 weeks of age, they were vaccinated against Newcastle Disease and
infectious bronchitis virus via drinking water. At 5 week of age, choanal cleft swabs
were taken (Branton et al., 1984), and chicks were bled from a wing vein and tested for
MG/MS antibodies using serum plate agglutination (SPA) and hemagglutinin inhibition
(HI) tests (Yoder., 1975). Choanal cleft swabs were placed into tubes containing Frey’s
broth medium (Frey et al., 1968) supplemented with thallium acetate and 106 IU
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penicillin-G/mL. Tubes were incubated at 37°C. Colonies with morpho logy suggestive
of Mycoplasma species were examined by an agar plate fluorescent antibody (FA)
method (Bass and Jasper, 1972).

Layer Housing and Management
At 10 week of age, eleven pullets were randomly assigned to each of sixteen
negative pressure biological units. The units were located in a previously described
USDA poultry disease isolation facility (Branton and Simmons, 1992). All birds were
wing-banded for purposes of identification and individual data collection. At initiation of
lay, the number of hens in each treatment unit was reduced to 10, resulting in a bird
density of 0.116m2 /bird. The temperatures inside each biological unit were maintained
25°C. Four negative pressure units were assigned to each of four treatments, and each
treatment was represented by one row of the four units. In trial II, the location of
treatments within the isolation facility was different from that in trial I to assure
environmental randomization between trials. At 18 week of age, duration of the artificial
lighting schedule was increased 15 min L : h 45 min D cycle was achieved in Trial 1, and
a 17 h 15 min L : 6 h 45 min D cycle was achieved in Trial II. These artificial lighting
programs were maintained until the end of both trials.

Pullet and Layer Diets
For the duration of each trial, chickens had ad libitum access to feed and water.
Birds received standard diets that met or exceeded National Research Council (1994)
recommendations. Diets were formulated according to the age of the birds and included
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the following: starter (0-6 weeks), grower (7-12 weeks), developer (13-18 weeks), pre- lay
(18-19 weeks), and layer (20-60 weeks). Ingredient percentages, calculated, and
determined analysis of these diets were described by Burnham et al. (2002a).

6/85 MG and FMG Inoculation
Control birds (Control) received sham inoculations in the right eye with 0.04 mL
of sterile Frey’s broth media at 10 weeks of age. A second treated group of birds were
inoculated with a 24- h broth culture of 6/85MG at 10 weeks of age (6/85MG-10). In a
third treatment group, birds inoculated with 6/85 MG at 10 weeks received an overlay of
FMG at 22 weeks (6/85MG-10, FMG-22); and a fourth treatment group were inoculated
with 6/85MG at 10 weeks followed by a 45 weeks overlay inoculatio n of FMG
(6/85MG-10, FMG-45). Mycoplasma gallisepticum organisms were advanced after
being received from S. H. Kleven (University of Georgia, Athens, GA) at the 212th
passage. Titers and passages of the inocula are presented in Table 1.

Mycoplasma Detection
At 58 weeks of age in both trials, 3 randomly selected hens from each replicate
unit in each of the 4 treatment groups (sham inoculated or inoculated with 6/85MG alone,
or 6/85MG with FMG overlays at 22 or 45 weeks of age during lay) were bled from a
wing vein and were swabbed to test for the presence of MG. Testing procedures at this
time were described for those at 5 weeks of age.
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Data Collection
In both trials individual BW were recorded at 10, 20, 24, 32, 43, 47, and 58
weeks. Weekly EP was recorded daily and analyzed weekly from weeks 22-58 and was
expressed as hen-day production. Furthermore, the total number of eggs produced per
hen (total hen EP) from weeks 22-58 was determined. Total hen EP was calculated as
total daily numbers of eggs produced as a percentage of total daily numbers of hens for
each replicate group over the entire 22-58 weeks production period. Mortality was
recorded daily and was expressed as a percentage of the total number of birds in each
unit.
In both trials, egg weight (EW) was determined weekly from 23 through 55
weeks and at weeks 24, 32, 43, 47, and 58, eggshell weight per unit of surface area
(SWUSA), and percentage yolk weight (PY), albumen weight (PA), eggshell weight
(PSW), yolk moisture (YM), and yolk lipid (YL) were determined. For determination of
the above mentioned internal egg and eggshell quality parameters (SWUSA, PY, PA,
PSW, YM, and YL) a total of 10 eggs were collected and used from each replicate unit.
If less than 10 eggs were collected on a given day, the rest were collected the following
day of the same week. Nevertheless, determinations were made on the same day that
eggs were collected. Eggshell weight per unit of eggshell surface area was determined
using the following formula: SWUSA = [eggshell weight (mg)/ SA (cm2 )], where SA =
3.9782*W0.37056] and where W is EW (g) (carter, 1975). Eggshell weight was determined
according to Brake et al (1984). Relative egg yolk, albumen, and shell weights were
expressed as percentages of total EW.

25

At the end of each trial (weeks 58), 2 birds from each replicate unit were
euthanized by cervical dislocation, their organs were removed, and the following
parameters were determined: liver weight, color, and moisture and lipid content; ovary
weight, mature follicle number (those that are = 12 mm in diameter); total oviduct
weight and length, total small intestine weight and length; oviduct segments
(infundibulum, magnum, isthmus, and vagina) weights and lengths, and small intestine
segment s (duodenum, jejunum, and ileum), weights and lengths; total oviduct and small
intestine weights were calculated as percentages of BW. Furthermore, oviduct and small
intestine segment weights were calculated as percentages of BW and total organ weight
and oviduct and small intestine segment lengths were calculated as percentages of total
organ length. The number of mature follicles in an ovary was assigned a category from
zero to six, where zero indicates the absence of mature follicles, and where six is the
number of maximum follicles recorded. The percentage of birds in each unit possessing
zero, one, two, three, four, five, or six follicles was calculated. Livers were examined for
color and for incidence of FLHS. Three categories were used for liver color and for
incidence of FLHS. Three categories were used for liver color assignment: neutral, red,
and yellow. The number of birds in each unit possessing a particular liver color was
expressed as a percentage of total number of birds examined. Also, birds with normal
livers or those exhibiting FLHS were calculated as percentages of the total number of
birds in each unit.
In both trials, blood samples from 2 tagged birds from each replicate unit were
collected at 24, 32, and 43 weeks of age for determination of whole blood hematocrit
(HCT), and serum calcium (SCA), triglycerides (STRIG), cholesterol (SCHOL), and
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plasma total protein (PP) concentrations. All data collected prior to weeks 22 were
designated as belonging to age interval I; all data collected from weeks 22 through 44
was designated as belonging to age internal II; and all data collected from weeks 45
through 58 were designated as belonging to internal III.

Quantitation of Yolk Moisture and Lipid Content
Yolk moisture concentration determination, yolk samples were dried according to
the procedure of Peebles et al. (1999) by using 2 g of yolk sample in a commercial oven
(Model EL20, General electric CO., Chicago Heights, IL 60411). After samples were
removed from the oven, they were allowed 30 min to cool and the dry weights were
recorded. Yolk moisture was calculated as the difference between the wet and dry weight
of the sample and was expressed as a percentage of wet sample weight. Yolk lipid was
extracted according to the procedure described by Bligh and Dryer (1959), and as
modified by Latour et al. (1998). A 3 g sample of fresh yolk was thoroughly mixed with
10 mL of methanol and 10 mL of chloroform in a 100 mL beaker. Mixing was done by
hand until the mixture was a pasty homogenate. Water (5 mL) was added to the
homogenate and the mixture was filtered through Whatman No. 1 filter paper in a Coors
Buchner funnel. The filtered mixture was pulled under vacuum suction into 50 mL
centrifuge tubes. Additionally, the beaker that contained the original 3 g sample was
rinsed with 3 mL of chloroform to extract any additional yolk, and that liquid was also
poured through filter paper as described above. Centrifuge tubes were spun in a
Beckman JB-6 centrifuge (Beckman Instruments, Inc., Fullerton, CA 93634) for 15 mins
at 3000 rpm in order to separate the alcohol and lipid. The centrifuged samples contained
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two well-defined layers (lower chloroform- lipid layer and upper methanol- water layer).
The upper layer was discarded and the lower chloroform- lipid layer was filtered through
a column of anahydrous sodium sulfate into a glass tube. The chloroform containing
lipid extract was placed into a V-Evap apparatus (Organomantion, Shrewsbury, MA
01545) and dried with a stream of air. Dried samples were weighed and the expression of
YL concentration was dry lipid sample weight as a percentage of total wet yolk sample
weight.

Liver Moisture and Lipid Content
Liver moisture analysis of a 2 g homogenized sample was performed according to
the procedure previously described for yolk moisture analysis. The expression of liver
moisture was the difference between wet and dry sample weight as a percentage of wet
sample weight. A homogenized liver sample was used for liver lipid analysis. Liver
lipid extraction was accomplished according to the procedure previously described for
YL extraction. The expression of liver lipid concentration was dry lipid weight as a
percentage of total wet sample weight.

Blood and Serum Constituents
Two tagged birds from each unit were selected and bled from the cutanea ulnae
wing vein. Blood (4-5 mL) was collected into tubes designed for either serum or plasma
collection. Two heparinized capillary tubes (75 mm long) were used on each blood
sample for HCT determination. Serum and plasma tubes were centrifuged at 4000 rpm
for 20 min. Then, serum and plasma samples were collected and stored at -20°C for later
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analysis. A Kodak Ektachem DT-60 analyzer (Eastman Kodak CO., Rochester, NY
14619) was used to determine levels of SCHOL and PP. A Kodak Ektachem DTSC
analyzer was used to assay serum samples for SCA. Hematocrit was expressed as
percentage blood packed cell volume. Concentrations of SCHOL, STRIG, and SCA
were expressed as mg/dL, and PP in g/dL.

Statistical Analysis
A completely randomized experimental design, with trial as a block, was
employed. Data prior to weeks 22 (age interval I), from weeks 22 through 44 (age
interval II), and from weeks 45 through 58 (age interval III) were analyzed separately.
The data of both trials were pooled then analyzed together. Therefore, the results from
both trials were not reported independently but were reported over both trials. Trial was
considered as a random effect. All data within each age interval were subjected to a
repeated measures analysis if parameters were examined at multiple age periods in an age
interval. Otherwise, data obtained at only one age period within an age interval was
subjected to one-way ANOVA.
In the first age interval, Controls and the 6/85MG-10 treatment group were
compared. In the second age interval, Controls and those having had 6/85MG-10, and
6/85MG-10, FMG-22 inoculations were compared. In the third age interval, Control,
6/85MG-10, 6/85MG-10, FMG-22, and 6/85MG-10, FMG-45 groups were compared.
Individual sample data within each of these replicate units were averaged prior to
analysis. Least-squares means were compared in the event of significant global effects
(Steel and Torrie, 1980). Global effects and differences among least-squared means were
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considered significant at P = .05. All data were analyzed using the MIXED procedure of
SAS software (SAS Institute, 2003).
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CHAPTER IV
RESULTS

All initial cultures of Mycoplasma as well as HI and SPA test results were
obtained from pullets at 5 wk of age and were negative for MG and MS. Samples of
serum obtained from control birds at 58 wk of age were SPA and HI negative for MG,
whereas the same tests were positive for MG in the 6/85MG and FMG inoculated hens.
Hens were considered to be free of MG when no detectable HI titers were exhibited, and
FA culture results showed no MG growth. All MG inoculated hens showed HI titers =
1:80 (geometric mean of 80.0), and were MG-positive (positive for MG fluorescence)
and MS- negative (negative for MS fluorescence) using FA tests.
No significant age or treatment main effects or age by treatment interactions were
found for bird mortality and BW in any of the 3 age intervals examined. However, mean
BW values at the various age periods examined in each age interval are provided in Table
2 for reference. There were significant age main effects for weekly EP in intervals II (P =
0.001) and III (P = 0.001) as shown in Table 3. Weekly EP was significantly increased
between wk 22 and 23 and between wk 23 and 25 in interval II. In that interval EP did
not change significantly between wk 25 and 44. Furthermore, weekly EP significantly
decreased at wk 47, increased at wk 49, and then decreased again at wk 50 and 54 in
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Interval III. In intervals II and III there was no significant treatment or age by treatment
interaction for weekly EP. There were no significant main effects due to treatment or age,
and there were no age by treatment interactions for weekly EP in interval I. Furthermore,
total EP across lay (interval II and III) was not significantly affected by treatment.
Significant age main effects were found for EW during intervals II (P = 0.0001)
and III (P= 0.003) as shown in Table 4. Egg weight increased as birds progressively
increased in age from 23 to 44 wk (interval II), and again from 45 to 55 wk (interval III).
Significant increases in EW in interval II occurred between wk 25 and 26, 29 and 31, 33
and 34, 36 and 37, 37 and 40, and 39 and 44. Also, significant increases in EW occurred
in interval III between wk 49 and 50. During intervals II and III, no significant treatment
main effects or age by treatment interactio ns were found, and in interval I no significant
effects of any kind were noted. There were also no significant effects of any kind for
relative eggshell conductance or SWUSA in intervals II and III or for egg shape index in
interval II. However, there was a significant age main effect (P = 0.04) for egg shape
index in interval III. Egg shape index decreased between wk 49 and 53. Egg shape index
at wk 49 and 53 was 76.0 and 75.3, respectively (pooled SEM = 0.36). There was no
significant treatment main effect or age by treatment interaction for egg shape index in
interval III.
There were no significant effects of any kind for yolk lipid concentration in age
intervals II and III or for YM content in interval III. However, there was a significant
treatment main effect (P = 0.03) for YM in interval II (Table 6). Yolk moisture content
was higher in birds inoculated with 6/85MG-10, FMG-22 compared to those inoculated
with 6/85MG at 10 wk alone and was also higher in birds inoculated with 6/85MG at 10
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wk alone compared to that in control birds. No significant age main effect or age by
treatment interactions were found for YM in interval II. Significant treatment main
effects were found for yolk palmitic (P = 0.02), oleic (P = 0.03), and linolenic (P = 0.04)
concentrations in interval III (Table 7). Palmitic acid concentrations were higher in the
6/85MG-10, FMG-22 inoculation group in comparison to the 6/85MG-10 and 6/85-10,
FMG-45 treatment groups, with the control group intermediate. Oleic acid
concentrations were lower in 6/85MG-10, FMG-22 and control groups in comparison to
the 6/85MG-10 group , with the 6/85MG-10, FMG-45 treatment group intermediate.
Linolenic acid concentrations in control birds were higher than those in the 6/85MG-10
birds with the 6/85MG-10, FMG-45 group intermediate. Furthermore, the 6/85MG-10,
FMG-45 birds had a higher yolk linolenic acid concentration than did the 6/85MG-10,
FMG-22 group, with the 6/85MG-10 group intermediate.
A significant treatment main effect (P = 0.0004) was found for liver moisture in
age interval III (Table 8). Liver moisture concentrations were higher in 6/85MG-10 and
6/85MG-10, FMG-45 treatment groups than in Control and 6/85MG-10, FMG-22 groups.
There was no treatment main effect for the following parameters in interval III: liver
weight as a percentage of BW; liver color and FLHS scores; follicular hierarchy; ovary,
total oviduct, infundibulum, magnum, uterus, vagina, and isthmus weights as percentages
of BW; infundibulum, magnum, uterus, vagina, and isthmus weights as percentages of
total oviduct weight; infundibulum, magnum, uterus, vagina, and isthmus lengths as
percentage s of total oviduct length; total small intestine, duodenum, ileum, and jejunum
weights as percentage s of BW; duodenum, jejunum, and ileum weights as percentage s of
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total small intestine weight; and duodenum, jejunum, and ileum lengths as percentages of
total small intestine length.
There was a significant age by treatment interaction (P = 0.03) for PP
concentration (Table 9) in age interval II, and there was a significant treatment main
effect (P = 0.04) for SCA at week 47 (interval III). Treatment differences in PP
concentration were found only at wk 32 in interval II. At wk 32 PP concentrations was
significantly lower for birds in the 6/85MG-10 treatment group in comparison to the
Control and 6/85MG-10, FMG-22 treatment groups. At week 47, SCA was higher in the
6/85MG-10, FMG-45 group compared to the Control and 6/85MG-10, FMG-22 groups.
Mean SCA in the Control, 6/85MG-10, FMG-45 treatment groups were 29.0, 34.5, 29.4,
and 36.9%, respectively (pooled SEM = 1.96%). No significant effects of any kind were
noted for SCHOL, STRIG, SCA, or HCT in interval II, or for SCHOL, STRIG, PP, or
HCT in interval III.
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CHAPTER V
DISCUSSION

At the end (58 weeks of age in both trials) of this study, SPA, HI, and FA tests
verified systemic infections in 6/85MG and FMG inoculated hens. Conversely, shaminoculated birds remained free of M. gallisepticum throughout the study. M.
gallisepticum manifestations generally occur in the respiratory system and lesions can
become extensive when complicated by other bacteria. Also, environmental factors such
as dust and ammonia, in conjunction with intensive rearing or stress, crowding, cold
weather, live virus vaccination, or natural virus infection may be important in the
incidence and severity of lesions (Jordan, 1972; Springer et al., 1974; Jordan, 1985).
However, mycoplasma infection is often subclinical or mild when there are no secondary
infections (Kerr and Olson, 1967). Birds in both trials were housed in biological isolation
units from 10 weeks of age through the remainder of the study, where natural infections
and other environmental stressors common in commercial operations were eliminated.
As a result, the 6/85MG and FMG inoculated hens exhibited no outward pathological
symptoms.
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In a previous study by Burnham et al. (2002a), weekly EP was delayed 1 week in
each of 2 experimental trials, whereas total EP was reduced in only 1 of the 2 trials in
layers inoculated with the F-strain of MG at 12 weeks of age. The decrease in total EP in
that trial became apparent at each week after week 42. Burnham et al. (2002b) later
suggested that alterations in the performance and egg characteristics of the layers
examined were related to mutual functional disturbances in the liver, ovary, and oviduct,
without any noticeable sign of intestinal changes. This suggestion was supported by
results showing a reduction in ripe ovarian follicle numbers as well as ovarian follicle
size, and increased incidences of FLHS in birds that demonstrated depressed performance
subsequent to FMG inoculation at 12 weeks of age. However, previous findings by
Evans and Hafez (1992) have indicated that while providing protection against field
strain MG (i.e. R-strain) infections, 6/85MG inoculations at 2 weeks of age did not
suppress growth in broiler chickens. Furthermore, Branton et al. (2002) showed that
6/85MG had no impact on commercial la yer performance or egg quality when inoculated
pre-lay (10 weeks of age). These results suggest that using 6/85MG rather than FMG
pre-lay may achieve the same level of protection against field strain MG infections, while
eliminating the noted negative effects of pre-lay FMG vaccines on EP (weekly and total).
In accordance with the results reported by Branton et al. (2002), inoculation of
commercial layers with 6/85MG at 10 weeks had no significant effect on weekly or total
EP in the current study. Furthermore, F-strain MG overlays at 22 and 45 week of age on
the 10 week 6/85MG inoculation had no significant effect on weekly or total EP. These
results confirm the hypothesis that pre- lay 6/85MG inoculations may be a suitable
substitute for pre- lay FMG inoculations, and that FMG overlays during lay on pre- lay
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6/85MG inoculations may also provide continual protection without eliciting any
subsequent suppressive affects on performance.
M. gallisepticum has shown the ability to invade cells (Winner et al., 2000),
thereby suggesting that MG may be capable of interfering with liver lipid metabolism.
Furthermore, MG is capable of passing through the mucosal barrier to cause systemic
infections, and it is possible to culture MG from the avian liver (Winner et al., 2000;
Sahu et al., 1976). Colonization of hepatic tissue by MG would be expected to alter liver
lipid metabolism with associated effects on liver weight, histology, and lipid and
moisture content. Further, reverse trends in liver moisture and lipid concentrations would
be expected. In this study, however, liver moisture concentration was significantly
higher in the 6/85MG-10 and 6/85MG-10, FMG-45 treatment groups in comparison to
6/85MG-10, FMG-22 and control treatment groups, while liver lipid content, histology,
FLHS incidence, and relative weight were not significantly affected by treatment.
Apparently, a significant alteration in the moisture content of the liver occurred without
an opposite significant effect on lipid content, and without subsequent affects on liver
weight and histology. The reason for this singular effect is not clear. Nevertheless, it is
important to note that the treatment effect on liver moisture had no impact on layer
performance.
In a companion report by Burnham et al. (2003b), in which egg yolk composition
was altered by 12 week FMG inoculations, it was also concluded that the alterations in
EP were associated with colonization of the liver by FMG with subsequent functional
disturbances in the metabolism of liver lipids and the deposition of circulating lipids in
the ovarian follicles. Furthermore, Burnham et al. (2003b) more specifically reported
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that yolk total lipid and cholesterol were decreased, and that linoleic, stearic, and
arachidonic acid concentrations were increased, and that yolk myristic, palmitoleic, and
oleic acid concentrations were decreased by 12 week FMG inoculations.
Similar to the results of Burnham et al. (2003b), treatment effects on yolk fatty
acid profile were found in this study. However, the specific changes in the fatty acid
profile of the yolk were different in response to treatment. The yolk concentrations of
palmitic, oleic, and linolenic acids were affected by the 10 week 6/85MG inoculation and
the FMG overlays in this study. Taken together, these results suggest that the inoculation
regimen used in this study may have affected fatty acid elongation and desaturation
processes in the hens’ liver endoplasmic reticula. Included in fatty acid synthesis,
palmitic acid is elongated and desaturated to form oleic acid. Oleic acid then undergoes
further desaturation to form linolenic acid (Lehninger, 1975). Palmitic acid
concentrations were significantly higher in 6/85MG-10, FMG-22 birds compared to
6/85MG-10 and 6/85MG-10, FMG-45 birds, with Control birds intermediate. Oleic acid
concentrations were significantly lower for the 6/85MG-10, FMG-22 and Control birds
when compared to the 6/85MG-10 birds, with the 6/85MG-10, FMG-45 birds
intermediate. Linolenic acid concentrations were higher in Control birds when compared
to 6/85MG-10 and6/85MG-10, FMG-22 treatment groups, with the 6/85MG-10, FMG-45
group intermediate. In general, the 6/85MG-10 inoculation may have blocked or
interfered with the desaturation of oleic to linolenic acid. A depression in the
desaturation process without a concomitant increase in oleic acid may have likewise
occurred when the 6/85MG-10 inoculation was given in conjunction with the FMG
overlay at 22 weeks. Also, the FMG overlay at 22 weeks in birds given a pre- lay
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6/85MG inoculation at 10 weeks may have interfered with the elongation of palmitic to
oleic acid, leading to an associated increase of palmitic acid in the 6/85MG-10, FMG-22
treated birds. However, as in liver moisture, these fatty acid differences had no affect or
relation to performance.
Burnham et al. (2003a) concluded that decreased concentrations of lipids
(STRIG) in the blood during lay may be directly responsible for reductions in YL, yolk
cholesterol, and changes in yolk fatty acid profile in birds having been inoculated with
FMG at 12 weeks of age. Conversely, there were no significant changes in any of the
blood lipids examined in this study due to treatment with 6/85MG at 10 weeks alone or in
combination with FMG overlays at 22 or 45 weeks of age. Therefore, the treatment
effects observed on the yolk lipids examined in this study were limited to yolk fatty acid
profile, and changes in the yolk fatty acid profile occurred without any blood lipid
changes. The bases for the differences in the relationship between the lipids in the blood
and yolk in response to the inoculation regimes used in the reports by Burnham et al.
(2003a,b) and in this study are not evident, but these results do indicate that the strain of
MG and the timing of inoculation can lead to changes in yolk lipid characteristics without
related changes in blood lipids and without having an effect on EP.
Unlike the results of Burnham et al. (2003b), who found no affect of a 12 week
FMG inoculation on yolk moisture content, in this study, yolk moisture was significantly
different between 6/85MG-10, FMG-22 and the Control birds, with 6/85MG-10
intermediate in Interval II. Furthermore, PP was found to be reduced in age interval II
(32 weeks of age) in birds given a 6/85MG-10 inoculation, and was subsequently
increased to control values when the 6/85MG-10 inoculation was given in conjunction
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with a 22 week FMG inoculation overlay. Burnham et al. (2003a) suggested that postpeak decreases in PP after a 12 week FMG inoculation may be associated with ovarian
follicular regression, reproductive tissue atrophy, and the onset of FLHS incidence.
However, no association between PP and incidences of follicular regression, FLHS, or
reproductive tissue regression were noted in this study. Warriss et al. (1003) has also
suggested that significant increases in PP and numerical increases in blood osmolaity
were indicative of dehydration in broilers during prolonged transport at slaughter age. It
is, therefore, suggested that associated changes in PP, yolk moisture, and liver moisture
reflect changes in the hydration statuses of the birds exposed to the inoculation regimens
in this study. These data also indicate that the inoculation treatments used influenced the
hydration status of the layers without impacting overall performance. It is noteworthy
that the 6/85MG-10 treatment alone led to concomitant increases in blood dilution
(decreased PP) and liver moisture content. This would suggest that the pre-lay
inoculation of 6/85MG may provide a hyd ration affect, which was manifested through
increased moisture levels in both the liver and plasma of the birds. Nevertheless, changes
in the moisture content of the yolk with treatment were not associated with those in the
liver and plasma, and the moisture content changes in the plasma and liver had no impact
on performance.
In conclusion, despite possible 6/85MG and FMG inoculation treatment and
timing effects on the liver, yolk, and PP of birds housed in environmentally controlled
conditions, these changes exerted no overall impact on layer performance. These results
establish that pre- lay 6/85MG inoculations may be a suitable substitute for pre- lay FMG
inoculations, and that FMG overlays during lay on pre- lay 6/85MG inoculations may also
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provide continual protection without eliciting any subsequent suppressive affects on
performance. Because these birds were housed in isolation units, these results do not
preclude the possibility that different or greater performance and physiological effects
may occur in birds infected pre-lay, at lay onset, or late in lay with 6/85MG or FMG
alone or in combination, when housed in facilities where there are increased levels of
environmental stress.
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CHAPTER VI
SUMMARY

The primary goal of the present study was to investigate the effects of a 6/85strain M. gallisepticum inoculation alone, and in conjunction with F-strain M.
gallisepticum overlays at 22 or 45 weeks of age during lay. F-strain MG has previously
been shown to negatively affect laying hens’ performances when given pre- lay or during
post-peak lay, whereas 6/85MG administered pre-lay has previously been shown to not
exert these negative effects.
In this study, yolk moisture and fatty acids, liver moisture, and PP were affected
by the inoculation regimes used. The PP and liver moisture changes may be indicative of
the hydration statuses of the birds during lay. Alterations in yolk palmitic, oleic, and
linolenic acid levels with treatment may have manifested disturbances in the desaturation
and elongation processes of fatty acid synthesis; however, as for liver and yolk moisture
concentration changes, these also did not effect EP at a significant level.
These results confirm that pre- lay 6/85G inoculations may be a suitable substitute
for pre- lay FMG inoculations, and that FMG overlays during lay on pre- lay 6/85MG
inoculations may also provide continual protection without eliciting any subsequent
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suppressive affects on performance. The data from this study indicates that using
6/85MG in conjunction with FMG does not negatively affect laying hen performance.
Furthermore, this inoculation combination offers benefits above the use of those achieved
through either inoculation alone. Also, because FMG is a more virulent strain, FMG may
offer stronger protection during lay than 6/85MG. These results would be of particular
interest in an industry setting in which flocks previously inoculated with 6/85MG are
acquired by a company comfortable with a traditionally used FMG inoculation regimen.
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TABLE 1. Titers used in 6/85MG @ 10 wk, FMG @ 22 wk, and FMG @ 43 wk of age
inocula in Trials 1 and 2.
Inoculum
6/85MG @10 wk
FMG @ 22 wk
FMG @ 45 wk

Trial 1
Trial 2
------------------------------(cfu/mL)---------------------------1.0 x 107
1.3 x 1010
7.5 x 1011
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1.0 x 106
1.0 x 1010
7.0 x 1011

TABLE 2. Body weight in age intervals I (20 wk), II (24, 32, and 43 wk), and III (47
wk)1
Age Interval
I2
II3
III4
20
24
32
43
47
--------------------------------------------------(kg)------------------------------------------------1.27

1.39

1.41

1

1.44

1.47

n = 16 replicate units for calculation of mean at each age period within each hen age
interval.
2
n = SEM based on pooled estimate of variance = 0.043.
3
n = SEM based on pooled estimate of variance = 0.027.
4
n = SEM based on pooled estimate of variance = 0.017.
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TABLE 3. Weekly egg production (EP; % hen day) in hen age intervals II (23-44 wk)
and III (45-54 wk)1
II

2

Age Interval

Wk of Age
EP
-------------------(%)-------------------22
42.3d
23
68.1c
24
79.6abc
25
83.8ab
26
85.4a
27
85.0a
28
82.9ab
29
83.3ab
30
82.5ab
31
77.8abc
32
82.1ab
33
84.7ab
34
79.7abc
35
74.1abc
36
81.4ab
37
73.0abc
38
81.5ab
39
75.8abc
40
74.9abc
41
75.6abc
42
75.7abc
43
71.9bc
44
74.2abc

III3
Wk of Age
EP
--------------(%)--------------45
81.1a
46
77.1a
47
75.6b
48
72.7b
49
78.2a
50
75.8b
51
70.4b
52
73.3b
53
72.1b
54
62.4c
-

a-c

= Means among weeks within age interval with no common superscript differ
significantly (P ≤ 0.05).
1
n = 16 replicate units for calculation of means at each age period within each hen age
group.
2
n = SEM based on pooled estimate of variance = 5.27.
3
n = SEM based on pooled estimate of variance = 3.76.
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TABLE 4. Weekly egg weight (EW) in hen age intervals II (23-44 wk) and III (45-55
wk)1

II2

Age Interval

IIII3
Week of Age
EW
Week of Age
EW
-----------------------(g)----------------------------------------------(g)-----------------23
47.2h
45
58.5b
h
24
48.5
46
59.0b
25
49.8h
47
59.0b
g
26
50.9
48
59.2b
27
51.8g
49
59.6b
g
28
52.4
50
60.0a
29
53.2g
51
60.0a
30
53.6fg
52
60.6a
f
31
54.1
53
60.1a
32
54.5f
54
60.0a
f
33
55.1
55
60.6a
34
55.6e
e
35
55.9
36
55.1e
d
37
57.0
cd
38
57.2
39
57.7bcd
40
57.9abc
41
57.8abc
abc
42
57.9
43
58.1ab
a
44
58.5
a-h
= Means among weeks with no common superscript differ significantly (P ≤ 0.05).
1
n = 16 replicate units for calculation of means at each age period within each hen age
group.
2
n = SEM based on pooled estimate of variance = 1.06.
3
n = SEM based on pooled estimate of variance = 0.75.
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TABLE 5. Percentage yolk weight (% of egg weight) in age interval II (24, 32, and 43
wk)1
Week of Age
24
32
43
Pooled SEM
--------------------------------------------------(%)-------------------------------------------24.3c

26.1b

27.8a

a-c
1

0.51

= Means among weeks with no common superscript differ significantly (P ≤ 0.05).
n = 16 replicate units used for calculation of means within each column (wk).
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TABLE 6. Egg yolk moisture concentration in control, 6/85MG at 10 wk (6/85MG-10),
and 6/85MG at 10 wk and FMG at 22 wk (6/85MG-10, FMG-22) treatment
groups in age interval II (across 24, 32, and 43 wk)1
Control

6/85MG-10

6/85MG-10,
Pooled SEM
FMG-22
--------------------------------------------------(%)-----------------------------------------------50.4b

51.2ab

51.7a

a,b
1

0.28

= Means among treatments with no common superscript differ significantly (P ≤ 0.05).
n = 12 replicate units used for calculation of means within each column (treatment).
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TABLE 7. Yolk Palmitic, oleic, and linolenic acid concentrations, (% of total yolk fatty
acids) in control, 6/85MG at 10 wk (6/85MG-10), 6/85MG at 10 wk and
FMG at 22 wk(6/85MG-10, FMG-22), and 6/85MG at 10 wk and FMG at 45
wk(6/85MG-10, FMG-45) treatment groups at age interval II (58 wk of age)1
Treatment

Palmitic acid
Oleic acid
Linolenic acid
----------------------------------(%)----------------------------------Control
31.7ab
31.2b
15.0a
b
a
6/85MG-10
31.3
32.2
11.3bc
6/85MG-10, FMG-22
32.1a
31.0b
9.7c
6/85MG-10, FMG-45
31.4b
31.6ab
13.8ab
SEM
0.28
0.43
0.54
a-c
1

= Means among column with no common superscript differ significantly (P ≤ 0.05).
n = 4 replicate units used for calculation of means within each treatment group.
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TABLE 8. Hen liver moisture concentration in control, 6/85MG at 10 wk (6/85MG-10),
6/85MG at 10 wk and FMG at 22 wk(6/85MG-10, FMG-22), and 6/85MG at
10 wk and FMG at 45 wk(6/85MG-10, FMG-45) treatment groups in age
Interval III (58 wk of age)1
Control

6/85MG-10

6/85MG-10,
6/85MG-10,
Pooled SEM
FMG-22
FMG-45
-----------------------------------------------(%)------------------------------------------------42.5b

47.1a

40.6b

a,b
1

46.7a

10.2

= Means among column with no common superscript differ significantly (P ≤ 0.05).
n = 4 replicate units used for calculation of means within each column (treatment).
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TABLE 9. Plasma total protein concentration in control, 6/85MG at 10 wk (6/85MG-10),
and 6/85MG at 10 wk and FMG at 22 wk (6/85MG-10, FMG-22) treatment
groups in age interval II(24, 32, and 43 wk)1

Treatment
Control
6/85MG-10
6/85MG-10, FMG22

Week of Age
24
32
43
------------------------------------(g/dL)-------------------------------4.10a
3.85b
4.43a

3.87
4.01
4.10

a,b

4.89
4.56
4.44

= Means within weeks with no common superscript differ significantly (P ≤ 0.05).
n = 4 replicate units used for calculation of treatment means within each column (wk).
2
n = SEM based on pooled estimate of variance = 0.344.
1
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